News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ablynx (ABLYF) and Merck Serono Further Strengthen Their Collaboration on Co-Discovery and Co-Development of Nanobodies


9/26/2013 9:20:31 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GHENT, Belgium, Sept. 26, 2013 (GLOBE NEWSWIRE) -- Ablynx (Euronext Brussels:ABLX) and Merck Serono, the biopharmaceutical division of Merck KGaA, Darmstadt, Germany,today announced that they have further expanded their relationship through a multi-year research alliance that could lead to at least four co-discovery and co-development collaborations.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES